Akebia blossoms: IPO upsized, raises $100M for CKD anemia effort
Akebia Therapeutics Inc. beat the target amount raised in its initial public offering to raise about $100 million, and started off trading with a bang, closing Thursday (NASDAQ:AKBA) at $26.70, up 57 percent.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter